bioRxivCell Biology
Effects of Post-Myocardial Infarction Heart Failure on the Bone Vascular Niche
J. Hoffmann, G. Luxan, W. T. Abplanalp, S.-F. Glaser, T. Rasper, A. Fischer, M. Muhly-Reinholz, D. John, B. Assmus, A. M. Zeiher, S. Dimmeler
Abstract
Bone vasculature provides protection and signals necessary to control stem cell quiescence and renewal1. Specifically, type H capillaries, which highly express Endomucin, constitute the endothelial niche supporting a microenvironment of osteoprogenitors and long-term hematopoietic stem cells2-4. The age-dependent decline in type H endothelial cells was shown to be associated with bone dysregulation and accumulation of hematopoietic stem cells, which display cell-intrinsic alterations and reduced functionality3. The regulation of bone vasculature by chronic diseases, such as heart failure is unknown. Here, we describe the effects of myocardial infarction and post-infarction heart failure on the vascular bone cell composition. We demonstrate an age-independent loss of type H bone endothelium in heart failure after myocardial infarction in both mice and in humans. Using single-cell RNA sequencing, we delineate the transcriptional heterogeneity of human bone marrow endothelium showing increased expression of inflammatory genes, including IL1B and MYC, in ischemic heart failure. Inhibition of NLRP3-dependent IL-1{beta} production partially prevents the post-myocardial infarction loss of type H vasculature in mice. These results provide a rationale for using anti-inflammatory therapies to prevent or reverse the deterioration of vascular bone function in ischemic heart disease.
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bone marrow mesenchymal stromal cells mediate cellular inflammation in HFpEF
Kyle I. Mentkowski, I‐Hsiu Lee, … Matthias Nahrendorf·bioRxiv·Mar 28, 2025
- Myeloid Cell-Derived IL1β Contributes to Pulmonary Vascular Remodeling in Heart Failure with Preserved Ejection Fraction
V. Agrawal, J. A. Kropski, … A. R. Hemnes·bioRxiv·May 18, 2023
- A single dose of intravenous human amniotic membrane-derived mesenchymal stem cells limits transmural infarction, reduces fibrosis size, and improves left ventricular systolic function in the myocardial ischemic/reperfusion model of rats
J.-W. Sung, Y.-T. Yeh, … S.-C. Wu·bioRxiv·Jul 30, 2022
- Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
J. M. Amrute, X. Luo, … K. Lavine·bioRxiv·Oct 17, 2022
- Splenic follicular B cells promote adverse cardiac remodeling after myocardial infarction via MHC II-dependent antigen presentation.
Obialunanma V. Ebenebe, Jana P. Lovell, … Luigi Adamo·bioRxiv·May 8, 2024
- A Novel ARNT-Dependent HIF-2α Signaling as a Protective Mechanism for Cardiac Microvascular Barrier Integrity and Heart Function Post-Myocardial Infarction